Does NELVUTAMIG Cause Immune-mediated hypophysitis? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Immune-mediated hypophysitis have been filed in association with NELVUTAMIG. This represents 3.3% of all adverse event reports for NELVUTAMIG.
9
Reports of Immune-mediated hypophysitis with NELVUTAMIG
3.3%
of all NELVUTAMIG reports
0
Deaths
4
Hospitalizations
How Dangerous Is Immune-mediated hypophysitis From NELVUTAMIG?
Of the 9 reports, 4 (44.4%) required hospitalization.
Is Immune-mediated hypophysitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NELVUTAMIG. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does NELVUTAMIG Cause?
Off label use (29)
Immune-mediated hepatitis (18)
Hypothyroidism (17)
Immune-mediated enterocolitis (16)
Malignant neoplasm progression (16)
Colitis (15)
Drug ineffective (14)
Immune-mediated hepatic disorder (14)
Fatigue (13)
Immune-mediated myocarditis (11)
What Other Drugs Cause Immune-mediated hypophysitis?
NIVOLUMAB (171)
PEMBROLIZUMAB (137)
IPILIMUMAB (135)
CARBOPLATIN (59)
PACLITAXEL (42)
CYCLOPHOSPHAMIDE (33)
EPIRUBICIN (23)
DURVALUMAB (14)
BEVACIZUMAB (12)
DOXORUBICIN (11)
Which NELVUTAMIG Alternatives Have Lower Immune-mediated hypophysitis Risk?
NELVUTAMIG vs NEMOLIZUMAB
NELVUTAMIG vs NEMOLIZUMAB-ILTO
NELVUTAMIG vs NEOMYCIN
NELVUTAMIG vs NEORAL
NELVUTAMIG vs NEOSTIGMINE